SELECTIVE INHIBITION OF KRAS SIGNALING BY COMBINATION OF LOW DOSE RAPAMYCIN AND PACLITAXEL IN VIVO by M. N. Yurova, D. R. Safina, I. V. Mizgirev

Subjects: “…kras…”
Get full text

The opposite association of HRAS and KRAS mutations with clinical variables of bladder cancer by M. P. Smal, A. I. Rolevich, T. N. Nabebina, S. A. Krasny, R. I. Goncharova

Subjects: Get full text

An exosome-based nanoplatform for siRNA delivery combined with starvation therapy promotes tumor cell death through autophagy, overcoming refractory KRAS-mutated tumors and restori... by Yurong Xiang, Qiang Liu, Kang Liu, Liuxian Chen, Fengjiao Chen, Tao Li, Siqi Li, Qiang Yu, Quan Lv, Zheng Xiang

Subjects: Get full text

Early monitoring of plasma KRAS G12C with digital PCR predicts antitumor response to immunotherapy or sotorasib in advanced NSCLC: A brief report by Andrea De Giglio, Federico Zacchini, Giulia Venturi, Alessandro Di Federico, Claudia Parisi, Filippo Gustavo Dall’Olio, Ilaria Ricciotti, Valentina Favorito, Ambrogio Gagliano, Dario De Biase, Thais Maloberti, Annalisa Altimari, Elisa Gruppioni, Giovanni Tallini, Barbara Melotti, Francesca Sperandi, Francesco Gelsomino, Lorenzo Montanaro, Andrea Ardizzoni

Subjects: Get full text

KRAS inhibition reverses chemotherapy resistance promoted by therapy-induced senescence-like in pancreatic ductal adenocarcinoma by Analia Meilerman Abuelafia, Patricia Santofimia-Castaño, Matias Estaras, Daniel Grasso, Eduardo Chuluyan, Gwen Lomberk, Raul Urrutia, Nelson Dusetti, Nicolas Fraunhoffer, Juan Iovanna

Subjects: Get full text

Introduction of the hybcell-based compact sequencing technology and comparison to state-of-the-art methodologies for KRAS mutation detection by Agnes Zopf, Roman Raim, Martin Danzer, Norbert Niklas, Rita Spilka, Johannes Pröll, Christian Gabriel, Andreas Nechansky, Markus Roucka

Subjects: “…KRAS…”
Get full text

Liver metastasis composed of pure squamous cell carcinoma component from pancreatic pure ductal adenocarcinoma: a case report by Yohei Mano, Keishi Sugimachi, Tomonari Shimagaki, Takahiro Tomino, Emi Onishi, Lingaku Lee, Terumasa Hisano, Yutaka Koga, Kenichi Taguchi, Masaru Morita, Yasushi Toh

Subjects: Get full text

KRAS Mutations as Predictive Biomarkers for First-Line Immune Checkpoint Inhibitor Monotherapy in Advanced NSCLC: A Systematic Review and Meta-Analysis by Filip Marković, Jelena Milin-Lazović, Nikola Nikolić, Aleksa Golubović, Mihailo Stjepanović, Milica Kontić

Subjects: “…KRAS…”
Get full text

Analysis and characterization of chondroitin/dermatan sulfate composition of lung adenocarcinoma tissues with different types of genetic alterations in ALK, EGFR and KRAS oncogenes by Domonkos Pál, Fanni Bugyi, Dávid Virág, Dániel Szabó, Gitta Schlosser, Ilona Kovalszky, Tünde Harkó, Judit Moldvay, Lilla Turiák

Subjects: Get full text

Wahania poziomu wody w wybranych jeziorach Niecki Nidziańskiej by Artur Zieliński, Michał Stachura, Krzysztof Jarzyna, Piotr Zagórski, Dariusz Wieczorek

Subjects: “…kras reprodukowany…”
Get full text

Correlation of PD-L1 and HIF-1 Alpha Expression with KRAS Mutation and Clinicopathological Parameters in Non-Small Cell Lung Cancer by Seda Er Özilhan, Safa Can Efil, Doğukan Çanakçı, Yetkin Ağaçkıran, Didem Şener Dede, Nilüfer Onak Kandemir, Mehmet Doğan, Tuba Dilay Kökenek Ünal, Merve Meryem Kıran, Serra Kayaçetin, Hilal Balta, Hayriye Tatlı Doğan

Subjects: Get full text

Investigating the correlation between IDO1/PD-L1 expression or co-expression and EGFR/KRAS gene mutations in advanced NSCLC by Zhidong Yin, Bohao Sun, Lu Cheng, Xi Xu, Sisi Wang, Shumei Wei, Er Jin

Subjects: Get full text

Analysis of Colorectal Cancer Gene Mutations and Application of Long Blocker Displacement Amplification Technology for High-Throughput Mutation Detection by Ping Lu, Xinglei Su, Sirui Leong, Xuehao Xiu, Ping Song, Junjie Peng, Yunpei Si

Subjects: Get full text

Frequency and effects of mutations in the KRAS gene on the survival of patients after surgical treatment of intrahepatic cholangiocarcinoma by B. N. Gurmikov, D. V. Kalinin, I. G. Nikitin, T. A. Zhinzhilo, A. N. Shipilova, A. V. Chzhao

Subjects: “…kras gene mutation…”
Get full text

Suppressor protein plasma levels and inflammatory indices in colorectal cancer patients by Nino Chigvinadze, Ia Pantsulaia, Teimuraz Lejava, Archil Aladashvili, Tsitsino Atamashvili, Nino Khvichia, Khatuna Rekhviashvili

Subjects: Get full text

Advanced organoid models for targeting Kras-driven lung adenocarcinoma in drug discovery and combination therapy by İsa Taş, Ruben Jacobs, Juliane Albrecht, Sebastian A. Barrientos, Josephine Åberg, Wondossen Sime, Hans Brunnström, Helena Persson, Julhash U. Kazi, Ramin Massoumi

Subjects: Get full text

Correction: KRAS and NRF2 drive metabolic reprogramming in pancreatic cancer cells: the influence of oxidative and nitrosative stress by Valentina Rapozzi, Clara Comuzzi, Eros Di Giorgio, Luigi E. Xodo

Subjects: “…KRAS…”
Get full text

Prognostic Value of KRAS/TP53 Status for Overall Survival in First-Line Monoimmunotherapy and Chemoimmunotherapy Treated Patients With Nonsquamous NSCLC in the Netherlands: A Brief... by Vincent D. de Jager, MD, Léon C. van Kempen, PhD, Betzabel N. Cajiao Garcia, MSc, T. Jeroen N. Hiltermann, MD, PhD, Anthonie J. van der Wekken, MD, PhD, Ed Schuuring, PhD, Stefan M. Willems, MD, PhD

Subjects: Get full text

Precise stratification of prognosis in pancreatic ductal adenocarcinoma patients based on pre- and postoperative genomic information by Kokichi Miyamoto, Ryuichi Yoshida, Kazuya Yasui, Kunitoshi Shigeyasu, Kazuhiro Yoshida, Tomokazu Fuji, Kosei Takagi, Yuzo Umeda, Kazuyuki Matsumoto, Yuki Fujii, Toshiaki Takahashi, Kazuya Moriwake, Masashi Kayano, Takeyoshi Nishiyama, Yasuo Nagai, Hideki Yamamoto, Hironari Kato, Hiroshi Tazawa, Mizuki Morita, Motoyuki Otsuka, Toshiyoshi Fujiwara

Subjects: Get full text

KRAS and NRF2 drive metabolic reprogramming in pancreatic cancer cells: the influence of oxidative and nitrosative stress by Valentina Rapozzi, Clara Comuzzi, Eros Di Giorgio, Luigi E. Xodo

Subjects: “…KRAS…”
Get full text